Bank of America’s BIND THERAPEUTICS INC BIND Stock Holding History

Bank of America’s Portfolio BIND Stock Details BIND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-7,449	Closed	-$3K	–	7706
2016 Q2	$3K	Buy	7,449 +396	+6%	+$325	﹤0.01%	6867
2016 Q1	$15K	Hold	7,053	–	–	﹤0.01%	6265
2015 Q4	$16K	Hold	7,053	–	–	﹤0.01%	6528
2015 Q3	$32K	Hold	7,053	–	–	﹤0.01%	6144
2015 Q2	$39K	Buy	7,053 +100	+1%	+$620	﹤0.01%	6057
2015 Q1	$39K	Sell	6,953 -1,200	-15%	-$7.37K	﹤0.01%	5777
2014 Q4	$44K	Buy	8,153 +1,200	+17%	+$9K	﹤0.01%	6418
2014 Q3	$60K	Sell	6,953 -16,720	-71%	-$165K	﹤0.01%	6389
2014 Q2	$312K	Buy	23,673 +23,562	+21,227%	+$231K	﹤0.01%	5096
2014 Q1	$1K	Buy	111 +11	+11%	+$144	﹤0.01%	7724
2013 Q4	$2K	Buy	+100	New	+$1.27K	﹤0.01%	7694

Bank of America's BIND Position: Q3 2016 in Review

Bank of America sold out of BIND THERAPEUTICS INC (BIND) in Q3 2016, closing a stake of 7,449 shares — an estimated $3K sold.

Bank of America first reported a position in BIND in Q4 2013 and held it in 11 quarters. The position peaked at $312K in Q2 2014. 0 funds tracked by Wall St. Rank hold BIND as of Q3 2016.

Bank of America reported no remaining BIND THERAPEUTICS INC position as of Q3 2016 after selling out during the quarter.
Bank of America sold 7,449 BIND THERAPEUTICS INC shares in Q3 2016, an estimated $3K.
Bank of America first reported a position in BIND THERAPEUTICS INC in Q4 2013 and held it in 11 quarters.
Bank of America's BIND THERAPEUTICS INC position peaked at $312K in Q2 2014.
0 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q3 2016.

Based on Bank of America's 13F filing for Q3 2016, filed 14 Nov 2016.